What if it wasn’t back to the drawing board every year for a new flu shot?
Flu virus mutates so quickly that one year's vaccine won't work on the next year's common strains. But a new way to create vaccines, called 'rational design,' might pave the way for more lasting solutions.
The final trials of the first effective Ebola vaccine show it's safe to use against an outbreak.
For viruses like dengue, being injected with the pathogen as in a vaccine can open the door to secondary infections.
Our immune system protects us but when it comes to some mosquito-borne disease, it can work against us. What are the implications for the development of a Zika virus vaccine?
For the next five years South Africa will be leading one of the latest large-scale trials for a vaccine for HIV.
Stay home if you get the flu.
Getting a flu shot reduces your risk of getting the flu, and it also helps the community. Here's why.
A vial of the Zika Virus Investigational DNA Vaccine from the NIH.
NIH Image Gallery/Flickr
The long vaccine development process is focused on ensuring production of the safest and most effective vaccine for use.
The Rotavirus vaccine is expensive and takes a long time to manufacture.
Rotavirus vaccines are expensive and take time to produce. For developing countries, the fact that the vaccines need cold storage also presents a challenge.
GMOs may very well have filled up that syringe.
Syringe image via www.shutterstock.com
Public health experts enlist the molecular biology tools that create genetically modified organisms – as well as the GMOs themselves – in the fight against emerging infectious diseases.
A nurse administers the HPV vaccine in Dallas, Texas in 2007.
Individual stories of perceived vaccine harms can undermine trust in vaccine safety, even if people don't believe the vaccine was to blame.
Glass sculpture representation of Human Immunodeficiency Virus structure.
A new animal study has shown injections of antibodies might protect against HIV infection, albeit for only a limited time.
An Ethiopian boy receives a polio vaccination. Africa has done well with polio eradication but lags behind other vaccination efforts.
Every year hundreds of thousands of children die from vaccine-preventable diseases. Africa leaders could change this if they improved vaccination efforts.
Nobel Laureate Barry Marshall talks to Eijkman Institute for Molecular Biology deputy director of translational research David Handojo Muljono in Indonesia.
Nobel Laureate Barry Marshal discovered that bacteria called Helicobacter pylori caused peptic ulcers. He is using the same bacteria to create probiotics and edible vaccines.
A pair of lungs infected with TB.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.
Microscope image of polymeric microneedles.
Half of all vaccines are wasted. Microneedles may be one way to tackle the problem.
Baby by Shutterstock
There are demands for older children to get the MenB vaccine – but what is the thinking behind the current guidance?
A women gets an HIV test. Sub-Saharan Africa accounts for the majority of the HIV deaths annually.
World Bank Collection/flickr
Two major clinical trials will be conducted in South Africa in 2016 to test ways of preventing new HIV infections.
Polio vaccinators carry boxes of polio vaccine drops as they head to the areas they have been appointed to administer the vaccine, in Karachi October 21 2014.
Researchers are piloting a smartphone app to collect better information about who is getting vaccinated and to design better incentives for health workers on vaccination drives.
A woman receives an MMR injection.
In light of the newly ignited political debate about vaccines, here in one article are some of the highlights of our vaccines coverage.
‘Leaky vaccines’ don’t affect the ability of the virus to reproduce and spread to others; they simply prevent it from causing disease.
U.S. Army Corps of Engineers Europe District/Flickr
Media coverage of a recent study involving a "leaky" vaccine raised questions about the possibility that they could make viruses more dangerous.
A health worker injects a woman with an Ebola vaccine during a trial in Monrovia, February 2 2015.
Was the Ebola vaccine 100% effective, or 100% lucky? The good money is on a percentage somewhere in between, but in truth, we will never know.